この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2012/4/251 分で読めます
Sanofi-aventis, U.S., LLC; Withdrawal of Approval of a New Drug Application for OFORTA
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of a new drug application (NDA) for OFORTA (fludarabine phosphate) Tablets held by sanofi-aventis, U.S., LLC (sanofi-aventis), 55 Corporate Dr., Bridgewater, NJ 08807-0977. Sanofi-aventis has voluntarily requested that approval of this application be withdrawn, thereby waiving its opportunity for a hearing.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →